Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration ...
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) To Present At Neuroscience And Biotech Investor Conferences
Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company focused on marketed products and development candidates, announced its participat ...
Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 8.4% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) fell 8.4% on Wednesday . The stock traded as low as $0.32 and last traded at $0.33. 80,811,016 shares traded hands during trading, ...
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.8% – Here’s Why
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) dropped 7.8% during mid-day trading on Tuesday . The company traded as low as $0.33 and last traded at $0.33.
Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a report published on Wednesday. The brokerage issued a hold rating on the stock. Tonix Pharmaceuticals ...
StockNews.com Begins Coverage on ENGlobal (NASDAQ:ENG)
StockNews.com began coverage on shares of ENGlobal (NASDAQ:ENG – Free Report) in a research report sent to investors on Wednesday. The firm issued a sell rating on the construction company’s stock.